Matthew Seavey has over a decade of drug development experience in small to large pharmaceutical companies, biotech and start-ups.  He has lead discovery programs from bench to IND filing and has managed assets from clinical development to product launch. Matthew is the founder and president of BioPoint Consulting, LLC, where he continues to serve clients passionate about science and interested in changing the future of healthcare by addressing unmet medical needs with novel therapeutic strategies.